NCT04328883View on ClinicalTrials.gov

Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

October 3, 2019

Study Completion Date

October 10, 2019

Conditions
Platelet Aggregation Inhibitors
Interventions
DRUG

Aspirin

Oral and inhaled ASA formulations

Trial Locations (1)

22042

Inova Fairfax Hospital, Falls Church

Sponsors
All Listed Sponsors
lead

Inova Health Care Services

OTHER